CHOLESTYRAMINE IN TYPE-IIA HYPERLIPOPROTEINEMIA - IS LOW-DOSE TREATMENT FEASIBLE

被引：16

作者：

ANGELIN, B

EINARSSON, K

机构：

来源：

ATHEROSCLEROSIS | 1981年 / 38卷 / 1-2期

关键词：

D O I：

10.1016/0021-9150(81)90101-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：33 / 38

页数：6

共 21 条

[1]

BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891

[2] CHOLESTYRAMINE - EFFECTIVE, TWICE-DAILY DOSAGE REGIMEN [J].

BLUM, CB ;

HAVLIK, RJ ;

MORGANROTH, J .

ANNALS OF INTERNAL MEDICINE, 1976, 85 (03) :287-289

[3]

Carlson K, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P32

[4]

DOWLING R H, 1970, Journal of Clinical Investigation, V49, P232, DOI 10.1172/JCI106232

[5] EFFECT OF CHOLESTYRAMINE ON ELIMINATION OF CHOLESTEROL AS BILE-ACIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE-II AND IV [J].

EINARSSON, K ;

HELLSTROM, K ;

KALLNER, M .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1974, 4 (06) :405-410

[6] BILE-ACID KINETICS IN RELATION TO SEX, SERUM-LIPIDS, BODY WEIGHTS, AND GALLBLADDER DISEASE IN PATIENTS WITH VARIOUS TYPES OF HYPERLIPOPROTEINEMIA [J].

EINARSSON, K ;

HELLSTROM, K ;

KALLNER, M .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (06) :1301-1311

[7]

EINARSSON K, 1979, LIVER QUANTITATIVE A, P233

[8]

FARAH JR, 1977, LANCET, V1, P59

[9]

Fredrickson D. S., 1978, METABOLIC BASIS INHE, P604

[10]

GLUECK CJ, 1977, PEDIATRICS, V59, P433

← 1 2 3 →